Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
3.590
-0.060 (-1.64%)
At close: Mar 24, 2026, 4:00 PM EDT
3.590
0.00 (0.00%)
After-hours: Mar 24, 2026, 4:25 PM EDT
Whitehawk Therapeutics Employees
Whitehawk Therapeutics had 23 employees as of December 31, 2025. The number of employees decreased by 17 or -42.50% compared to the previous year.
Employees
23
Change
-17
Growth
-42.50%
Revenue / Employee
$324,773
Profits / Employee
-$936,182
Market Cap
169.44M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 23 | -17 | -42.50% |
| Sep 30, 2025 | 22 | -31 | -58.49% |
| Jun 30, 2025 | 21 | -49 | -70.00% |
| Mar 31, 2025 | 18 | -57 | -76.00% |
| Dec 31, 2024 | 40 | -49 | -55.06% |
| Sep 30, 2024 | 53 | -35 | -39.77% |
| Jun 30, 2024 | 70 | -19 | -21.35% |
| Mar 31, 2024 | 75 | -5 | -6.25% |
| Dec 31, 2023 | 89 | 10 | 12.66% |
| Sep 30, 2023 | 88 | 12 | 15.79% |
| Jun 30, 2023 | 89 | 22 | 32.84% |
| Mar 31, 2023 | 80 | 26 | 48.15% |
| Dec 31, 2022 | 79 | 40 | 102.56% |
| Sep 30, 2022 | 76 | 55 | 261.90% |
| Jun 30, 2022 | 67 | 57 | 570.00% |
| Mar 31, 2022 | 54 | 44 | 440.00% |
| Dec 31, 2021 | 39 | 31 | 387.50% |
| Sep 30, 2021 | 21 | 13 | 162.50% |
| Mar 31, 2021 | 10 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 293 |
| Protalix BioTherapeutics | 226 |
| Adagene | 138 |
| Molecular Partners AG | 134 |
| Caribou Biosciences | 97 |
| Immunic | 92 |
| Tenaya Therapeutics | 70 |
| Connect Biopharma Holdings | 62 |
WHWK News
- 7 days ago - Whitehawk Therapeutics to Highlight its Next-Generation ADC Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026 - PRNewsWire
- 12 days ago - Whitehawk Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights - PRNewsWire
- 26 days ago - Whitehawk Therapeutics to Participate in Upcoming Investor Conferences - PRNewsWire
- 4 weeks ago - Whitehawk Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference - PRNewsWire
- 2 months ago - Whitehawk Therapeutics Advances to Clinical Stage with IND Clearance for HWK-007 and Announces IND Submission for HWK-016 - PRNewsWire
- 4 months ago - Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer - PRNewsWire
- 4 months ago - Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference - PRNewsWire
- 4 months ago - Whitehawk Therapeutics to Present at Jefferies Global Healthcare Conference in London - PRNewsWire